Literature DB >> 31332655

Effect of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Randomized, Multicenter Trial (EPICC Study).

Manuel Méndez Bailón1, Jose María Cepeda Rodrigo2, Noel Lorenzo-Villalba3, Jose Manuel Cerqueiro4, Jose Curbelo García5, Elpidio Calvo Manuel6, Francisco Javier Martín-Sánchez7, Ramon Bover Freire8, Pilar Cubo Romano9, Luis Manzano Espinosa10, Jose Carlos Arévalo-Lorido11, Jose Manuel Casas Rojo9, Juan Torres Macho9.   

Abstract

INTRODUCTION AND
OBJECTIVES: Pulmonary congestion (PC) is associated with an increased risk of hospitalization and death in patients with heart failure (HF). Lung ultrasound has shown to be highly sensitive for detecting PC in HF. The aim of this study is to evaluate whether lung ultrasound-guided therapy improves 6-month outcomes in patients with HF compared with conventional treatment.
MATERIALS AND METHODS: Randomized, multicenter, single-blind clinical trial in patients discharged from Internal Medicine Departments after hospitalization for decompensated HF. Participants will be assigned 1:1 to receive treatment guided according to the presence of lung ultrasound signs of congestion (semi-quantitative evaluation of B lines and the presence of pleural effusion) versus clinical assessment of congestion. The primary outcome is the combination of cardiovascular death and readmission for HF at 6 months.
CONCLUSIONS: The results of this study will provide more evidence about the impact of lung ultrasound on treatment monitoring in patients with chronic HF.

Entities:  

Keywords:  Heart failure; Lung ultrasound; Therapy; Trial

Mesh:

Year:  2019        PMID: 31332655     DOI: 10.1007/s10557-019-06891-z

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  4 in total

1.  Combined use of cardiopulmonary ultrasound in the diagnosis of pulmonary edema in patients with heart failure: a retrospective analysis.

Authors:  Mengjun Shen; Hongwei Chen; Yang Cong
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 2.  The impact of lung ultrasound on clinical-decision making across departments: a systematic review.

Authors:  Micah L A Heldeweg; Lian Vermue; Max Kant; Michelle Brouwer; Armand R J Girbes; Mark E Haaksma; Leo M A Heunks; Amne Mousa; Jasper M Smit; Thomas W Smits; Frederique Paulus; Johannes C F Ket; Marcus J Schultz; Pieter Roel Tuinman
Journal:  Ultrasound J       Date:  2022-01-10

3.  Lung ultrasound-guided treatment for heart failure: An updated meta-analysis and trial sequential analysis.

Authors:  Yan Li; Hu Ai; Na Ma; Peng Li; Junhong Ren
Journal:  Front Cardiovasc Med       Date:  2022-08-22

4.  The Effects of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Results from the EPICC Randomized Controlled Trial.

Authors:  Juan Torres-Macho; Jose Manuel Cerqueiro-González; Jose Carlos Arévalo-Lorido; Pau Llácer-Iborra; Jose María Cepeda-Rodrigo; Pilar Cubo-Romano; Jose Manuel Casas-Rojo; Raúl Ruiz-Ortega; Luis Manzano-Espinosa; Noel Lorenzo-Villalba; Manuel Méndez-Bailón
Journal:  J Clin Med       Date:  2022-08-22       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.